Regentis Biomaterials Ltd. (RGNT)

Price & Market Data

Price: $2.16

Daily Change: -$0.05 / 2.31%

Daily Range: $1.95 - $2.18

Market Cap: $11,187,457

Daily Volume: 16,034

Performance Metrics

1 Week: 8.54%

1 Month: -19.05%

3 Months: -43.33%

6 Months: -70.14%

1 Year: -70.14%

YTD: -68.43%

About Regentis Biomaterials Ltd. (RGNT)

Explore Regentis Biomaterials Ltd. (RGNT)'s performance at a glance. Current price: 2.16, daily change: -$0.05 / 2.31%. Market cap: 11,187,457. Focus on its YTD and 3-month performance.

Company Details

Employees: 10

Sector: Health technology

Industry: Biotechnology

Country: Israel

Details

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

Selected stocks

Generate Biomedicines, Inc. (GENB)

Suja Life, Inc. (SUJA)

Spring Valley Acquisition Corp. IV (SVIV)

Soren Acquisition Corp. (SORN)

Iron Horse Acquisitions II Corp. (IRHO)